PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11716810-3	2001	The present study addressed these issues employing the dopaminergic agonist, quinelorane, which efficaciously stimulated G-protein activation (as assessed by [35S]GTPgammaS binding) at cloned hD2 (and hD3) receptors.	Sulfur-35	159-162	immunoglobulin heavy diversity 2-15	Homo sapiens	192-195	
10431754-7	1999	Roxindole potently blocked dopamine-stimulated [35S]GTPgammaS binding at hD2 receptors (pkappaB = 9.05).	Sulfur-35	48-51	immunoglobulin heavy diversity 2-15	Homo sapiens	73-76	
9765336-5	1998	In contrast, raclopride inhibited stimulation of [35S]-GTPgammaS binding at hD2 sites by DA with a Kb of 1.4 nM, whereas S 18126 (> 1000 nM) and L 745,870 (> 1000 nM) were inactive.	Sulfur-35	50-53	immunoglobulin heavy diversity 2-15	Homo sapiens	76-79